why choose us

First received: November 14, 2022

Clinical Trial: Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Influenza Immunization

Study Type: INTERVENTIONAL


Official Title: Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adults Aged 18 Years and Older

Brief Summary: The purpose of this study is to evaluate the safety and immunogenicity of a single intramuscular (IM) injection of up to 3 dose levels of Quadrivalent Influenza mRNA Vaccine MRT5410 compared to an active control (QIV SD, QIV HD [adults ? 65 years of age only], or RIV4) in adults 18 years of age and older.

Read more